| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |